REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 39 filers reported holding REDHILL BIOPHARMA LTD in Q3 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $586,000,000 | – | 83,250 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ibex Investors LLC | 1,892,593 | $15,292,000 | 6.10% |
| GAGNON SECURITIES LLC | 281,080 | $2,271,000 | 0.36% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 2,029,195 | $16,396,000 | 0.32% |
| Annandale Capital, LLC | 43,532 | $352,000 | 0.29% |
| WOODWARD DIVERSIFIED CAPITAL, LLC | 23,000 | $186,000 | 0.12% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 20,328 | $164,000 | 0.10% |
| Claret Asset Management Corp | 54,972 | $444,000 | 0.09% |
| Migdal Insurance & Financial Holdings Ltd. | 890,339 | $7,194,000 | 0.08% |
| Shay Capital LLC | 47,800 | $386,000 | 0.08% |
| ARS Investment Partners, LLC | 77,714 | $628,000 | 0.08% |